<DOC>
	<DOCNO>NCT00047775</DOCNO>
	<brief_summary>A placebo-controlled trial BiDil add standard therapy African-American patient heart failure .</brief_summary>
	<brief_title>African-American Heart Failure Trial</brief_title>
	<detailed_description>The overall objective confirmation BiDil â€™ Safety Efficacy African-American ( AFA ) Patients Moderate Severe Symptomatic Heart Failure .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>African American male female 18 year old . NYHA Class 3 &amp; 4 . Have either rest LVEF le equal 35 % ( method ) rest LVIDD great 2.9 cm/m2 BSA ( great 6.5 cm ) LVEF le 45 % ( echocardiogram ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
</DOC>